-
Evaluation of parkinsonism and striatal dopamine transporter loss in patients with spinocerebellar ataxia type 6
-
Evaluation of quality of life (QOL), patient- and clinician-reported outcomes with deutetrabenazine treatment of chorea in Huntington disease in first-HD
-
Evaluation of regional changes in striatal DAT binding in a progressing Parkinson’s disease (PD) cohort: Lessons for imaging biomarker assessment in disease-modifying therapeutic trials
-
Evaluation of respiratory and depression levels of patients with Parkinson’s disease
-
Evaluation of stigmatization and quality of life before and after botulinum toxin treatment in hemifacial spasm
-
Evaluation of the [ 99mTc] – TRODAT- 1 SPECT in the diagnosis of Parkinson’s disease and other movement disorders
-
Evaluation of the accuracy of stereotactic DBS electrode implantation by post-operative image fusion
-
Evaluation of the role of oxidative stress in Parkinson’s disease and Parkinson plus syndrome
-
Evaluation of the surface based measures to discriminate progressive supranuclear palsy from corticobasal syndrome
-
Evidence of striatal dopaminergic dysfunction Sydenham’s chorea in remission with (99m)Tc-TRODAT-1 SPECT
- « Previous Page
- 1
- …
- 76
- 77
- 78
- 79
- 80
- …
- 207
- Next Page »